K Number
K981373
Date Cleared
1998-05-27

(41 days)

Product Code
Regulation Number
862.1050
Panel
CH
Reference & Predicate Devices
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

Measurement of BAP is intended for use as an aid in the:

management of postmenopausal osteoporosis and Paget's disease.

monitoring of postmenopausal women on hormonal or bisphosphonate therapy

prediction of skeletal response to hormonal therapy in postmenopausal women.

Device Description

Not Found

AI/ML Overview

I am sorry, but the provided text from the FDA 510(k) letter for the Alkphase-B® Assay Kit does not contain information about the acceptance criteria, study details, sample sizes, expert qualifications, or ground truth establishment. The document is an FDA letter granting substantial equivalence, not a detailed study report. Therefore, I cannot generate the requested table and paragraphs based on this input.

§ 862.1050 Alkaline phosphatase or isoenzymes test system.

(a)
Identification. An alkaline phosphatase or isoenzymes test system is a device intended to measure alkaline phosphatase or its isoenzymes (a group of enzymes with similar biological activity) in serum or plasma. Measurements of alkaline phosphatase or its isoenzymes are used in the diagnosis and treatment of liver, bone, parathyroid, and intestinal diseases.(b)
Classification. Class II.